Evidence map›Paper›PMID 40624469›Full record

Observational studyBMC infectious diseases2025

Factors associated with cross infections in COVID-19 patients in a Tunisian intensive care unit: a longitudinal study.

Rim Chehaibi, Farah Azouzi, Hela Ghali, Sameh Boughattas, Soumaya Ketata, Lamia Tilouche, Houyem Said Latiri, Abdelhalim Trabelsi, Walid Naija, Olfa Bouallegue

Abstract readObservational Study
PubMed Full text at PMC Publisher
In one paragraph

Observational study in BMC infectious diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Rim ChehaibiLaboratory of Microbiology, Sahloul University Hospital, Sousse, Tunisia.
Farah AzouziLaboratory of Microbiology, Sahloul University Hospital, Sousse, Tunisia.
Hela GhaliFaculty of Medicine of Sousse, University of Sousse, Sousse, Tunisia. hela.ghali@outlook.com.
Sameh BoughattasLaboratory of Microbiology, Sahloul University Hospital, Sousse, Tunisia.
Soumaya KetataLaboratory of Microbiology, Sahloul University Hospital, Sousse, Tunisia.
Lamia TiloucheLaboratory of Microbiology, Sahloul University Hospital, Sousse, Tunisia.
Houyem Said LatiriFaculty of Medicine of Sousse, University of Sousse, Sousse, Tunisia.
Abdelhalim TrabelsiLaboratory of Microbiology, Sahloul University Hospital, Sousse, Tunisia.
Walid NaijaFaculty of Medicine of Sousse, University of Sousse, Sousse, Tunisia.
Olfa BouallegueLaboratory of Microbiology, Sahloul University Hospital, Sousse, Tunisia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundSuperinfections in intensive care units (ICU) are usually due to multidrug resistant microorganisms and impact the patient prognosis. The aim of this study was to identify risk factors associated with cross infections in COVID-19 ICU patients.

methodsThis was an observational longitudinal study performed in the intensive care unit of University Hospital Sahloul. All patients diagnosed with COVID-19 and admitted to ICU were included. The data were extracted prospectively from medical records and from the microbiology laboratory chart. To identify factors associated with cross infections among COVID-19 patients, binary logistic regression model was used. Significant p value was set at 0.05.

resultsA total of 319 patients were included with a mean age of 62 ± 13 years old. Average length of stay was 9 ± 7 days. A total of 196 cross infections were diagnosed and 102 (32%) patients had at least one cross infection. Ventilator-acquired pneumonia and bacteremia were diagnosed in 62% and 52% of patients. The mean time to onset of the first cross infection was 8 ± 5 days. A total of 206 strains were responsible for cross infections with a majority of Acinetobacter baumannii (53,9%). Independent risk factors associated with cross infections in COVID-19 ICU patients were age > 75 years old (RR = 2.61; CI

conclusionsIn COVID-19 ICU patients, the prevalence of cross infection was 32% within 8 ± 5 days. The main microorganism was Acinetobacter baumannii. Independent risk factors associated with cross infections were advanced age, and venous catheter use.

Indexed as

COVID-19Cross InfectionIntensive Care UnitsAdultAgedAged, 80 and overBacteremiaFemaleHumansLength of StayLongitudinal StudiesMaleMiddle AgedPneumonia, Ventilator-AssociatedRisk FactorsSARS-CoV-2Acinetobacter baumanniiCOVID-19Cross infectionIntensive care unitsMultidrug-resistant

Identifiers

PMID40624469
PMCPMC12235926

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.